The Complete Blood Count (CBC) in the peripheral blood of G93A mice receiving different MNC hUCB cell doses showed no differences in red blood cell (RBC) count, levels of hemoglobin (Hb) and hematocrit (Htc) compared to Media, CsA, hTgn and C57 BL/6 mice.
To further explore the delivery characteristics of CL-R8-LP and PEG-LP liposomes into cells after the sufficient tumor accumulation, tumor sections from C26 tumor-bearing mice receiving different liposomes were observed by CLSM.
In the above mentioned study, authors have studied four groups of mice receiving different drugs (vehicle, clopidogrel, angiotensin II and clopidogrel + angiotensin II) and estimated the mRNA levels of several cytokines, blood pressure and cardiac myocyte size.
Differences in tumour volumes were analysed statistically by a t-test comparing the slopes of the regression lines for plots of tumour volume vs days after MMC treatment in mice receiving different treatments.
To examine whether HD-Ad vector delivery could cause tissue damage, we performed H&E staining of the retinas from mice that received different doses of HD-Ad-CMV-LacZ.
The mice received four different diets.
In vitro experiments showed that IgE suppresses CD4+ T-cell IL10 expression (Fig 1E and F), but we did not document significant change in plasma IL10 levels between Apoe−/− and Apoe−/− Fcer1a−/− mice, or those that received different types of CD4+ or CD8+ T cells (Supplementary Fig S12A C).
In contrast, although IgE suppressed IL10 production from isolated CD4+ T cells in vitro (Fig 1E and F), we did not detect significant differences in plasma IL10 levels between Apoe−/− and Apoe−/− Fcer1a−/− mice, or those that received different types of CD4+ T cells, CD8+ T cells, MCs, or macrophages (Supplementary Fig S12A E).
Next, F1 recipient mice were sub-grouped and received different doses of heparanase (1 µg/mouse/day, 5 µg/mouse/day) for 7 days starting on the day of transplantation, or 35 µg heparanase per mouse, twice weekly for 5 weeks.
